BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bernatik T, Strobel D, Hahn EG, Becker D. Doppler measurements: a surrogate marker of liver fibrosis?: . European Journal of Gastroenterology & Hepatology 2002;14:383-7. [DOI: 10.1097/00042737-200204000-00008] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Bolognesi M, Quaglio C, Bombonato G, Guido M, Cavalletto L, Chemello L, Merkel C, Rugge M, Gatta A, Sacerdoti D. Hepatitis C virus reinfection in liver transplant patients: Evaluation of liver damage progression with echo-color doppler. Liver Transpl 2008;14:616-24. [DOI: 10.1002/lt.21407] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
2 Liu CH, Hsu SJ, Lin JW, Hwang JJ, Liu CJ, Yang PM, Lai MY, Chen PJ, Chen JH, Kao JH. Noninvasive diagnosis of hepatic fibrosis in patients with chronic hepatitis C by splenic Doppler impedance index. Clin Gastroenterol Hepatol. 2007;5:1199-1206.e1. [PMID: 17916547 DOI: 10.1016/j.cgh.2007.07.017] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
3 Jiang H, Zheng T, Duan T, Chen J, Song B. Non-invasive in vivo Imaging Grading of Liver Fibrosis. J Clin Transl Hepatol. 2018;6:198-207. [PMID: 29951365 DOI: 10.14218/jcth.2017.00038] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 4.7] [Reference Citation Analysis]
4 Virarkar M, Morani AC, Taggart MW, Bhosale P. Liver Fibrosis Assessment. Semin Ultrasound CT MR 2021;42:381-9. [PMID: 34130850 DOI: 10.1053/j.sult.2021.03.003] [Reference Citation Analysis]
5 Lim AK, Patel N, Eckersley RJ, Goldin RD, Thomas HC, Cosgrove DO, Taylor-Robinson SD, Blomley MJ. Hepatic vein transit time of SonoVue: a comparative study with Levovist. Radiology 2006;240:130-5. [PMID: 16720867 DOI: 10.1148/radiol.2401041517] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 2.7] [Reference Citation Analysis]
6 Cui XW, Friedrich-Rust M, De Molo C, Ignee A, Schreiber-Dietrich D, Dietrich CF. Liver elastography, comments on EFSUMB elastography guidelines 2013. World J Gastroenterol. 2013;19:6329-6347. [PMID: 24151351 DOI: 10.3748/wjg.v19.i38.6329] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
7 Rocha HLOG, Diniz ALD, Borges VFDAE, Salomão FC. Assessment of portal venous index as a non-invasive method for diagnosing liver fibrosis in patients with chronic hepatitis C. Arq Gastroenterol 2012;49:14-8. [DOI: 10.1590/s0004-28032012000100004] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
8 Abbattista T, Ridolfi F, Ciabattoni E, Marini F, Bendia E, Brunelli E, Busilacchi P. Diagnosis of liver cirrhosis by transit-time analysis at contrast-enhanced ultrasonography. Radiol Med. 2008;113:860-874. [PMID: 18587531 DOI: 10.1007/s11547-008-0292-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
9 Lim AK, Taylor-Robinson SD, Patel N, Eckersley RJ, Goldin RD, Hamilton G, Foster GR, Thomas HC, Cosgrove DO, Blomley MJ. Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C. Gut. 2005;54:128-133. [PMID: 15591518 DOI: 10.1136/gut.2003.030965] [Cited by in Crossref: 106] [Cited by in F6Publishing: 89] [Article Influence: 6.6] [Reference Citation Analysis]
10 Cocciolillo S, Parruti G, Marzio L. CEUS and Fibroscan in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. World J Hepatol. 2014;6:496-503. [PMID: 25068001 DOI: 10.4254/wjh.v6.i7.496] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
11 Stankovic Z. Four-dimensional flow magnetic resonance imaging in cirrhosis. World J Gastroenterol. 2016;22:89-102. [PMID: 26755862 DOI: 10.3748/wjg.v22.i1.89] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
12 Horowitz JM, Venkatesh SK, Ehman RL, Jhaveri K, Kamath P, Ohliger MA, Samir AE, Silva AC, Taouli B, Torbenson MS, Wells ML, Yeh B, Miller FH. Evaluation of hepatic fibrosis: A review from the society of abdominal radiology disease focus panel. Abdom Radiol (NY). 2017;42:2037-2053. [PMID: 28624924 DOI: 10.1007/s00261-017-1211-7] [Cited by in Crossref: 55] [Cited by in F6Publishing: 45] [Article Influence: 13.8] [Reference Citation Analysis]
13 Yeom SK, Lee CH, Cha SH, Park CM. Prediction of liver cirrhosis, using diagnostic imaging tools. World J Hepatol 2015;7:2069-79. [PMID: 26301049 DOI: 10.4254/wjh.v7.i17.2069] [Cited by in Crossref: 43] [Cited by in F6Publishing: 31] [Article Influence: 7.2] [Reference Citation Analysis]
14 Karanjia RN, Crossey MM, Cox IJ, Fye HK, Njie R, Goldin RD, Taylor-Robinson SD. Hepatic steatosis and fibrosis: Non-invasive assessment. World J Gastroenterol 2016;22:9880-97. [PMID: 28018096 DOI: 10.3748/wjg.v22.i45.9880] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
15 Schneider AR, Teuber G, Kriener S, Caspary WF. Noninvasive assessment of liver steatosis, fibrosis and inflammation in chronic hepatitis C virus infection. Liver Int 2005;25:1150-5. [PMID: 16343065 DOI: 10.1111/j.1478-3231.2005.01164.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
16 Salvatore V, Borghi A, Peri E, Colecchia A, Li Bassi S, Montrone L, Di Donato R, Conti F, Crespi C, Festi D, Bernardi M, Andreone P, Bolondi L. Relationship between hepatic haemodynamics assessed by Doppler ultrasound and liver stiffness. Digestive and Liver Disease 2012;44:154-9. [DOI: 10.1016/j.dld.2011.08.021] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
17 Sharma S, Khalili K, Nguyen GC. Non-invasive diagnosis of advanced fibrosis and cirrhosis. World J Gastroenterol 2014;20:16820-30. [PMID: 25492996 DOI: 10.3748/wjg.v20.i45.16820] [Cited by in CrossRef: 89] [Cited by in F6Publishing: 62] [Article Influence: 14.8] [Reference Citation Analysis]
18 Shen L, Li JQ, Zeng MD, Lu LG, Fan ST, Bao H. Correlation between ultrasonographic and pathologic diagnosis of liver fibrosis due to chronic virus hepatitis. World J Gastroenterol. 2006;12:1292-1295. [PMID: 16534888 DOI: 10.3748/wjg.v12.i8.1292] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 38] [Article Influence: 2.7] [Reference Citation Analysis]
19 Haimerl M, Poelsterl S, Beyer L, Wiesinger I, Nießen C, Stroszczynski C, Wiggermann P, Jung E, Jung F, Gori T. Chronic liver disease: Quantitative MRI vs CEUS-based microperfusion. CH 2017;64:435-46. [DOI: 10.3233/ch-168112] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 2.8] [Reference Citation Analysis]
20 Ridolfi F, Abbattista T, Busilacchi P, Brunelli E. Contrast-enhanced ultrasound evaluation of hepatic microvascular changes in liver diseases. World J Gastroenterol. 2012;18:5225-5230. [PMID: 23066317 DOI: 10.3748/wjg.v18.i37.5225] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
21 Searle J, Mendelson R, Zelesco M, Sanford J, Cheng W, McKinstry C, Ramsay D. Non-invasive prediction of the degree of liver fibrosis in patients with hepatitis C using an ultrasound contrast agent. A pilot study. J Med Imaging Radiat Oncol. 2008;52:130-133. [PMID: 18373803 DOI: 10.1111/j.1440-1673.2008.01930.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
22 Lim AK, Patel N, Eckersley RJ, Kuo YT, Goldin RD, Thomas HC, Cosgrove DO, Taylor-Robinson SD, Blomley MJ. Can Doppler sonography grade the severity of hepatitis C-related liver disease? AJR Am J Roentgenol. 2005;184:1848-1853. [PMID: 15908541 DOI: 10.2214/ajr.184.6.01841848] [Cited by in Crossref: 57] [Cited by in F6Publishing: 47] [Article Influence: 3.6] [Reference Citation Analysis]
23 Xu G, Li F, Mao Y. Portal pressure monitoring-state-of-the-art and future perspective. Ann Transl Med. 2019;7:583. [PMID: 31807564 DOI: 10.21037/atm.2019.09.22] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
24 Chen CH, Lin ST, Yang CC, Yeh YH, Kuo CL, Nien CK. The accuracy of sonography in predicting steatosis and fibrosis in chronic hepatitis C. Dig Dis Sci. 2008;53:1699-1706. [PMID: 17939048 DOI: 10.1007/s10620-007-0048-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
25 Horowitz JM, Kamel IR, Arif-tiwari H, Asrani SK, Hindman NM, Kaur H, Mcnamara MM, Noto RB, Qayyum A, Lalani T. ACR Appropriateness Criteria ® Chronic Liver Disease. Journal of the American College of Radiology 2017;14:S103-17. [DOI: 10.1016/j.jacr.2017.02.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
26 Haimerl M, Brünn K, Poelsterl S, Beyer L, Wiesinger I, Stroszczynski C, Jung E, Wiggermann P, Jünger M, Krüger-genge A, Jung F. Quantitative evaluation of real-time maximum liver capacity (LiMAx) and time intensity curve (TIC) analysis in CEUS-based microperfusion. CH 2017;67:373-82. [DOI: 10.3233/ch-179217] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
27 Abbattista T, Ridolfi F, Consalvo GT, Brunelli E. Hepatic Vein Arrival Time for Diagnosis of Liver Cirrhosis: A 10-Year Single-Center Experience With Contrast-Enhanced Sonography. J Ultrasound Med 2016;35:2121-8. [PMID: 27503751 DOI: 10.7863/ultra.15.09026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
28 Kim SY, Jeong WK, Kim Y, Heo JN, Kim MY, Kim TY, Sohn JH. Changing waveform during respiration on hepatic vein Doppler sonography of severe portal hypertension: comparison with the damping index. J Ultrasound Med 2011;30:455-62. [PMID: 21460144 DOI: 10.7863/jum.2011.30.4.455] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
29 Horowitz JM, Kamel IR, Arif-tiwari H, Asrani SK, Hindman NM, Kaur H, Mcnamara MM, Noto RB, Qayyum A, Lalani T. ACR Appropriateness Criteria ® Chronic Liver Disease. Journal of the American College of Radiology 2017;14:S391-405. [DOI: 10.1016/j.jacr.2017.08.045] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
30 Soker G, Bahadir Ozturk A, Gulek B, Kuscu F, Bilge Doğan U, Yilmaz C. Doppler ultrasonography helps discriminate between cirrhotic and non-cirrhotic patients with viral B and C hepatitis. Diagn Interv Imaging. 2015; Nov 30. [Epub ahead of print]. [PMID: 26652726 DOI: 10.1016/j.diii.2015.05.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
31 Goertz RS, Sturm J, Pfeifer L, Wildner D, Wachter DL, Neurath MF, Strobel D. ARFI cut-off values and significance of standard deviation for liver fibrosis staging in patients with chronic liver disease. Annals of Hepatology 2013;12:935-41. [DOI: 10.1016/s1665-2681(19)31299-2] [Cited by in Crossref: 16] [Article Influence: 2.0] [Reference Citation Analysis]
32 Schneider AR, Teuber G, Paul K, Nikodem A, Duesterhoeft M, Caspary WF, Stein J. PATIENT AGE IS A STRONG INDEPENDENT PREDICTOR OF 13C-AMINOPYRINE BREATH TEST RESULTS: A COMPARATIVE STUDY WITH HISTOLOGY, DUPLEX-DOPPLER AND A LABORATORY INDEX IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION. Clin Exp Pharmacol Physiol 2006;33:300-4. [DOI: 10.1111/j.1440-1681.2006.04365.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
33 Takahashi H, Suzuki M, Shigefuku R, Okano M, Hiraishi T, Takagi R, Noguchi Y, Hattori N, Hatsugai M, Nakahara K. Xenon computed tomography can evaluate the improvement of hepatic hemodynamics before and after endoscopic injection sclerotherapy. J Gastroenterol. 2013;48:1353-1361. [PMID: 23397117 DOI: 10.1007/s00535-013-0756-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
34 Gharibvand MM, Asare M, Motamedfar A, Alavinejad P, Momeni M. Ultrasound shear wave elastography and liver biopsy to determine liver fibrosis in adult patients. J Family Med Prim Care 2020;9:943-9. [PMID: 32318450 DOI: 10.4103/jfmpc.jfmpc_828_19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Bonekamp S, Kamel I, Solga S, Clark J. Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately? J Hepatol. 2009;50:17-35. [PMID: 19022517 DOI: 10.1016/j.jhep.2008.10.016] [Cited by in Crossref: 128] [Cited by in F6Publishing: 107] [Article Influence: 9.8] [Reference Citation Analysis]
36 El-Shabrawi MH, El-Raziky M, Sheiba M, El-Karaksy HM, El-Raziky M, Hassanin F, Ramadan A. Value of duplex Doppler ultrasonography in non-invasive assessment of children with chronic liver disease. World J Gastroenterol 2010;16:6139-44. [PMID: 21182231 DOI: 10.3748/wjg.v16.i48.6139] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
37 Takahashi H, Suzuki M, Ikeda H, Kobayashi M, Sase S, Yotsuyanagi H, Maeyama S, Iino S, Itoh F. Evaluation of quantitative portal venous, hepatic arterial, and total hepatic tissue blood flow using xenon CT in alcoholic liver cirrhosis: comparison with liver cirrhosis C. Alcohol Clin Exp Res. 2007;31:S43-S48. [PMID: 17331165 DOI: 10.1111/j.1530-0277.2006.00285.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
38 Aubé C, Winkfield B, Oberti F, Vuillemin E, Rousselet MC, Caron C, Calès P. New Doppler ultrasound signs improve the non-invasive diagnosis of cirrhosis or severe liver fibrosis. Eur J Gastroenterol Hepatol. 2004;16:743-751. [PMID: 15256975 DOI: 10.1097/01.meg.0000108357.41221.e5] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 2.4] [Reference Citation Analysis]
39 Ravaioli F, Montagnani M, Lisotti A, Festi D, Mazzella G, Azzaroli F. Noninvasive Assessment of Portal Hypertension in Advanced Chronic Liver Disease: An Update. Gastroenterol Res Pract 2018;2018:4202091. [PMID: 29977287 DOI: 10.1155/2018/4202091] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 7.3] [Reference Citation Analysis]
40 Haimerl M, Jung E, Beyer L, Pregler B, Dollinger M, Sieroń D, Niessen C, Stroszczynski C, Wiggermann P, Prantl L, Jung E, Jung F. Chronic liver disease: Correlation of CEUS-based microperfusion and indocyanine green clearance. CH 2015;61:195-204. [DOI: 10.3233/ch-151990] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
41 Ikeda H, Suzuki M, Kobayashi M, Takahashi H, Matsumoto N, Maeyama S, Iino S, Sase S, Itoh F. Xenon computed tomography shows hemodynamic change during the progression of chronic hepatitis C. Hepatol Res. 2007;37:104-112. [PMID: 17300705 DOI: 10.1111/j.1872-034x.2007.00020.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
42 Takahashi H, Shigefuku R, Yoshida Y, Ikeda H, Matsunaga K, Matsumoto N, Okuse C, Sase S, Itoh F, Suzuki M. Correlation between hepatic blood flow and liver function in alcoholic liver cirrhosis. World J Gastroenterol 2014;20:17065-74. [PMID: 25493018 DOI: 10.3748/wjg.v20.i45.17065] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
43 Takahashi H, Suzuki M, Ikeda H, Kobayashi M, Sase S, Yotsuyanagi H, Maeyama S, Iino S, Itoh F. Evaluation of quantitative portal venous, hepatic arterial, and total hepatic tissue blood flow using xenon CT in alcoholic liver cirrhosis-comparison with liver cirrhosis related to hepatitis C virus and nonalcoholic steatohepatitis. Alcohol Clin Exp Res. 2010;34 Suppl 1:S7-S13. [PMID: 18986379 DOI: 10.1111/j.1530-0277.2008.00755.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
44 Kim MY, Jeong WK, Baik SK. Invasive and non-invasive diagnosis of cirrhosis and portal hypertension. World J Gastroenterol. 2014;20:4300-4315. [PMID: 24764667 DOI: 10.3748/wjg.v20.i15.4300] [Cited by in CrossRef: 64] [Cited by in F6Publishing: 54] [Article Influence: 10.7] [Reference Citation Analysis]
45 Lu LG, Zeng MD, Wan MB, Li CZ, Mao YM, Li JQ, Qiu DK, Cao AP, Ye J, Cai X, Chen CW, Wang JY, Wu SM, Zhu JS, Zhou XQ. Grading and staging of hepatic fibrosis, and its relationship with noninvasive diagnostic parameters. World J Gastroenterol 2003;9:2574-8. [PMID: 14606100 DOI: 10.3748/wjg.v9.i11.2574] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 41] [Article Influence: 2.2] [Reference Citation Analysis]
46 Nasr P, Hilliges A, Thorelius L, Kechagias S, Ekstedt M. Contrast-enhanced ultrasonography could be a non-invasive method for differentiating none or mild from severe fibrosis in patients with biopsy proven non-alcoholic fatty liver disease. Scandinavian Journal of Gastroenterology 2016;51:1126-32. [DOI: 10.3109/00365521.2016.1172336] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]